The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Clinical Applications of PET in Brain Tumors
Open accessAbstract
Malignant gliomas and metastatic tumors are the most common brain tumors. Neuroimaging plays a significant role clinically. In low-grade tumors, neuroimaging is needed to evaluate recurrent disease and to monitor anaplastic transformation into high-grade tumors. In high-grade and metastatic tumors, the imaging challenge is to distinguish between recurrent tumor and treatment-induced changes such as radiation necrosis. The current clinical gold standard, MRI, provides superior structural detail but poor specificity in identifying viable tumors in brain treated with surgery, radiation, or chemotherapy. (18)F-FDG PET identifies anaplastic transformation and has prognostic value. The sensitivity and specificity of (18)F-FDG in evaluating recurrent tumor and treatment-induced changes can be improved significantly by co-registration with MRI and potentially by delayed imaging 3-8 h after injection. Amino acid PET tracers are more sensitive than (18)F-FDG in imaging recurrent tumors and in particular recurrent low-grade tumors. They are also promising in differentiating between recurrent tumors and treatment-induced changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,135
Walker, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., Norrell, H. A., Owens, G., Ransohoff, J., Wilson, C. B., et al. (1978) · Journal of Neurosurgery · doi:10.3171/jns.1978.49.3.0333 · Cited by 1,667
Ohgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H.-J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., & Mangner, T. J. (1998) · Nature Medicine · doi:10.1038/3337 · Cited by 1,204
Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery
Vecht, C. J., Haaxma‐Reiche, H., Noordijk, E. M., Padberg, G. W., Voormolen, J. H. C., Hoekstra, F. H., Tans, J. T. J., Lambooij, N., Metsaars, J. A. L., Wattendorff, A. R., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330605 · Cited by 1,049
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
Pignatti, F., van den Bent, M., Curran, D., Debruyne, C., Sylvester, R., Therasse, P., Áfra, D., Cornu, P., Bolla, M., Vecht, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.121 · Cited by 955
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
Walker, M. D., Strike, T. A., & Sheline, G. E. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90553-4 · Cited by 854
Dopamine visualized in the basal ganglia of living man
Garnett, E. S., Firnau, G., & Nahmias, C. (1983) · Nature · doi:10.1038/305137a0 · Cited by 644
Pauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
KOMOTAR, R. J., WILSON, D. A., & CONNOLLY, E. S. (2005) · Neurosurgery · doi:10.1093/neurosurgery/57.1.n7a · Cited by 570
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G. E., Langen, K., & Piers, D. (2001) · PubMed · Cited by 558
Simpson, J. R., Horton, J., Scott, C., Curran, W. J., Rubin, P., Fischbach, J., Isaacson, S., Rotman, M., Asbell, S. O., Nelson, J. S., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90203-8 · Cited by 535
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Buck, A. K., Halter, G., Schirrmeister, H., Kotzerke, J., Wurziger, I., Glatting, G., Mattfeldt, T., Neumaier, B., Reske, S. N., & Hetzel, M. (2003) · PubMed · Cited by 439
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen, W., Cloughesy, T. F., Kamdar, N. V., Satyamurthy, N., Bergsneider, M., Liau, L. M., Mischel, P. S., Czernin, J., Phelps, M. E., & Silverman, D. H. S. (2005) · PubMed · Cited by 437
Self-citationDi Chiro, G., Oldfield, E., Wright, D., De Michele, D., Katz, D., Patronas, N., Doppman, J., Larson, S., Ito, M., & Kufta, C. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.1.189 · Cited by 422
Limitations of stereotactic biopsy in the initial management of gliomas
Jackson, R. J., Fuller, G. N., Abi-Said, D., Lang, F. F., Gokaslan, Z. L., Shi, W. M., Wildrick, D. M., & Sawaya, R. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.193 · Cited by 416
Chen, W., Silverman, D. H. S., Delaloye, S., Czernin, J. G., Kamdar, N. V., Pope, W. B., Satyamurthy, N., Schiepers, C. W., & Cloughesy, T. F. (2006) · PubMed · Cited by 407
Self-citationValidation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
Rasey, J. S., Grierson, J. R., Wiens, L. W., Kolb, P. D., & Schwartz, J. L. (2002) · PubMed · Cited by 406
National survey of patterns of care for brain-tumor patients
Mahaley, M. S., Mettlin, C., Natarajan, N., Laws, E. R., & Peace, B. B. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.6.0826 · Cited by 383
Grosu, A. L., Weber, W. A., Franz, M., Stärk, S., Piert, M., Thamm, R., Gumprecht, H., Schwaiger, M., Molls, M., & Nieder, C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.056 · Cited by 373
Leighton, C., Fisher, B., Bauman, G., Depiero, S., Stitt, L., MacDonald, D., & Cairncross, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1294 · Cited by 365
Neurologic Complications of Cancer
Wen, P. Y., & Glantz, M. J. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00100-7 · Cited by 361
Long-term outcome of low-grade oligodendroglioma and mixed glioma
Olson, J. D., Riedel, E., & DeAngelis, L. M. (2000) · Neurology · doi:10.1212/wnl.54.7.1442 · Cited by 340
Vesselle, H. J., Grierson, J. R., Muzi, M., Pugsley, J. M., Schmidt, R. A., Rabinowitz, P., Peterson, L. M., Vallières, E., & Wood, D. E. (2002) · PubMed · Cited by 300
Patronas, N. J., Di Chiro, G., Brooks, R. A., DeLaPaz, R. L., Kornblith, P. L., Smith, B. H., Rizzoli, H. V., Kessler, R. M., Manning, R. G., Channing, M., et al. (1982) · Radiology · doi:10.1148/radiology.144.4.6981123 · Cited by 298
Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma
P�pperl, G., G�tz, C., Rachinger, W., Gildehaus, F., Tonn, J. C., & Tatsch, K. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1590-1 · Cited by 293
A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma
Burkhard, C., Di Patre, P.-L., Schüler, D., Schüler, G., Yaşargil, M. G., Yonekawa, Y., Lütolf, U. M., Kleihues, P., & Ohgaki, H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.6.1170 · Cited by 279
Prediction of Pathology and Survival by FDG PET in Gliomas
Padma, M. V., Said, S., Jacobs, M., Hwang, D. R., Dunigan, K., Satter, M., Christian, B., Ruppert, J., Bernstein, T., Kraus, G., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1025665820001 · Cited by 277
Athanassiou, H., Synodinou, M., Maragoudakis, E., Paraskevaidis, M., Verigos, C., Misailidou, D., Antonadou, D., Saris, G., Beroukas, K., & Karageorgis, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.331 · Cited by 272
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
Henze, M., Schuhmacher, J., Hipp, P., Kowalski, J., Becker, D. W., Doll, J., Mäcke, H. R., Hofmann, M., Debus, J., & Haberkorn, U. (2001) · PubMed · Cited by 265
Bruehlmeier, M., Roelcke, U., Schubiger, P. A., & Ametamey, S. M. (2004) · PubMed · Cited by 214
PET in differentiation of recurrent brain tumor from radiation injury.
Langleben, D. D., & Segall, G. M. (2000) · PubMed · Cited by 210
Positron emission tomography imaging of brain tumors
Wong, T. Z., van der Westhuizen, G. J., & Coleman, R. E. (2002) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(02)00033-3 · Cited by 207
Floeth, F. W., Pauleit, D., Wittsack, H.-J., Langen, K. J., Reifenberger, G., Hamacher, K., Messing-Jünger, M., Zilles, K., Weber, F., Stummer, W., et al. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.2.0318 · Cited by 193
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours
Weckesser, M., Langen, K., Rickert, C. H., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1705-8 · Cited by 192
Sugar and Amino Acid Transport by Cells in Culture — Differences between Normal and Malignant Cells
Deykin, D., Balko, C., & Isselbacher, K. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197204272861707 · Cited by 190
[18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors
Choi, S. J., Kim, J. S., Kim, J. H., Oh, S. J., Lee, J. G., Kim, C. J., Ra, Y. S., Yeo, J. S., Ryu, J. S., & Moon, D. H. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1742-3 · Cited by 189
Fluorinated amino acids for tumour imaging with positron emission tomography
Laverman, P., Boerman, O. C., Corstens, F. H., & Oyen, W. J. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0716-y · Cited by 189
Ishiwata, K., Kubota, K., Murakami, M., et al. (1993) · PubMed · Cited by 186
Molecular Imaging of Proliferation in Malignant Lymphoma
Buck, A. K., Bommer, M., Stilgenbauer, S., Juweid, M., Glatting, G., Schirrmeister, H., Mattfeldt, T., Tepsic, D., Bunjes, D., Mottaghy, F. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1955 · Cited by 185
Spence, A. M., Muzi, M., Mankoff, D. A., O’Sullivan, S., Link, J. M., Lewellen, T. K., Lewellen, B., Pham, P., Minoshima, S., Swanson, K. R., et al. (2004) · PubMed · Cited by 182
Wagner, M., Seitz, U., Buck, A. K., Neumaier, B., Schultheiß, S., Bangerter, M., Bommer, M., Leithäuser, F., Wawra, E., Munzert, G. M., et al. (2003) · PubMed · Cited by 178
Cher, L., Murone, C., Lawrentschuk, N., Ramdave, S., Papenfuss, A. T., Hannah, A., O'Keefe, G. J., Sachinidis, J. I., Berlangieri, S. U., Fabinyi, G., et al. (2006) · PubMed · Cited by 175
Yap, C. S., Czernin, J., Fishbein, M. C., Cameron, R. B., Schiepers, C., Phelps, M. E., & Weber, W. A. (2006) · Chest · doi:10.1378/chest.129.2.393 · Cited by 166
Neurologic Complications of Cancer
O'Neill, B. P. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.319-a · Cited by 166
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze, M., Dimitrakopoulou‐Strauss, A., Milker-Zabel, S., Schuhmacher, J., Strauss, L. G., Doll, J., Mäcke, H. R., Eisenhut, M., Debus, J., & Haberkorn, U. (2005) · PubMed · Cited by 163
De Witte, O., Levivier, M., Violon, P., Salmon, I., Damhaut, P., Wikler, D., Hildebrand, J., Brotchi, J., & Goldman, S. (1996) · Neurosurgery · doi:10.1097/00006123-199609000-00007 · Cited by 158
Low-grade gliomas: an update on pathology and therapy
Cavaliere, R., Lopes, M. B. S., & Schiff, D. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70222-2 · Cited by 139
“Facilitated” Amino Acid Transport is Upregulated in Brain Tumors
Miyagawa, T., Oku, T., Uehara, H., Desai, R., Beattie, B. J., Gelovani, J. G., & Blasberg, R. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199805000-00005 · Cited by 137
Toyohara, J., Waki, A., Takamatsu, S., Yonekura, Y., Magata, Y., & Fujibayashi, Y. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00286-x · Cited by 136
In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
Francis, D., Freeman, A., Visvikis, D., Costa, D. C., Luthra, S. K., Novelli, M. R., Taylor, I., & Ell, P. J. (2003) · Gut · doi:10.1136/gut.52.11.1602 · Cited by 134
Stege, E. M. B., Kros, J. M., de Bruin, H. G., Enting, R. H., van Heuvel, I., Looijenga, L. H. J., van der Rijt, C. C. D., Smitt, P. A. E. S., & van den Bent, M. J. (2005) · Cancer · doi:10.1002/cncr.20828 · Cited by 126
Positron emission tomography in clinical neurology
Herholz, K., & HEISS, W. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.05.002 · Cited by 119
Outcome and Cost of Craniotomy Performed to Treat Tumors in Regional Academic Referral Centers
Long, D. M., Gordon, T. A., Bowman, H. M., Etzel, A., Burleyson, G. P., Betchen, S. A., Garonzik, I. M., & Brem, H. (2003) · Neurosurgery · doi:10.1227/01.neu.0000057745.48813.93 · Cited by 112
F-Dopa as an amino acid tracer to detect brain tumors.
Heiss, W., Wienhard, K., Wagner, R. L., Lanfermann, H., Thiel, A., Herholz, K., & Pietrzyk, U. (1996) · PubMed · Cited by 112
Watling, C., Lee, D. H., Macdonald, D. R., & Cairncross, J. G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.9.1886 · Cited by 106
Tralins, K. S., Douglas, J. G., Stelzer, K. J., Mankoff, D. A., Silbergeld, D. L., Rostomily, R. C., Hummel, S. M., Scharnhorst, J., Krohn, K. A., Spence, A. M., et al. (2002) · PubMed · Cited by 99
Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Hustinx, R., Smith, R. J., Bénard, F., Bhatnagar, A., & Alavi, A. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050487 · Cited by 98
Diffusely Infiltrative Low-Grade Gliomas in Adults
Lang, F. F., & Gilbert, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2399 · Cited by 88
Therapeutic targets in radiotherapy
Brown, J. M. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01482-6 · Cited by 80
True tracers: comparing FDG with glucose and FLT with thymidine
Krohn, K. A., Mankoff, D. A., Muzi, M., et al. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.04.004 · Cited by 78
Chemotherapy response criteria in malignant glioma
Grant, R., Liang, B. C., Slattery, J. M. A., Greenberg, H. S., & Junck, L. (1997) · Neurology · doi:10.1212/wnl.48.5.1336 · Cited by 67
Henze, M., Mohammed, A., Schlemmer, H., et al. (2004) · PubMed · Cited by 59
Positron emission tomography imaging of brain tumors
Spence, A. M., Mankoff, D. A., & Muzi, M. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00097-2 · Cited by 51
Yee, R. E., Cheng, D. W., Huang, S.-C., Namavari, M., Satyamurthy, N., & Barrio, J. R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00787-0 · Cited by 35
Enhanced Detection of Brain Tumors by [18F]Fluorodeoxyglucose PET with Glucose Loading
Ishizu, K., Sadato, N., Yonekura, Y., Nishizawa, S., Magata, Y., Tamaki, N., Tsuchida, T., Okazawa, H., Tanaka, F., Miyatake, S., et al. (1994) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199401000-00003 · Cited by 28
Cerebral metastases—a therapeutic update
Cavaliere, R., & Schiff, D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0263 · Cited by 16
Cited by
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
A survey of MRI-based medical image analysis for brain tumor studies
Bauer, S., Wiest, R., Nolte, L.-P., & Reyes, M. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/13/r97 · Cited by 1,036
Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4207-9 · Cited by 556
Zhou, J., Tryggestad, E., Wen, Z., Lal, B., Zhou, T., Grossman, R., Wang, S., Yan, K., Fu, D.-X., Ford, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2268 · Cited by 526
Metadata
- Authors
- Chen, W.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2007-08-17
- Volume
- 48
- Issue
- 9
- Pages
- 1468-1481
- ISSN
- 0161-5505 (ISSN-L)
- OpenAlex
- W2122394188
- Cited by
- 449
- References
- 73
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.